PSYK ETF

Rentabilität für sechs Monate: 0%
Kommission: 0.75%
Kategorie: Health & Biotech Equities
Name Industrie Aktie, % P/BV P/S P/E EV/Ebitda Dividendenrendite
#1 Sage Therapeutics, Inc. Sage Therapeutics, Inc. Healthcare 8.13 0.7095 8 -1.32 -0.6368 0
#2 Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd. Healthcare 7.04 8.05 13.12 -1.45 -3.97 0
#3 Jazz Pharmaceuticals plc Healthcare 6.93 1.98 1.99 14.49 8.67 0
#4 Intra-Cellular Therapies, Inc. Intra-Cellular Therapies, Inc. Healthcare 6.54 7.5 12.65 -182.12 -71.28 0
#5 Relmada Therapeutics, Inc. Relmada Therapeutics, Inc. Healthcare 5.73 0.3898 0 -0.2142 -0.1249 0
#6 Myriad Genetics, Inc. Myriad Genetics, Inc. Healthcare 5.68 1.76 1.47 -4.29 -21.39 0
#7 COMPASS Pathways plc COMPASS Pathways plc Healthcare 5.26 1.65 0 -1.91 -0.6857 0
#8 Neurocrine Biosciences Neurocrine Biosciences Healthcare 4.51 5.49 6.03 41.64 22.57 0
#9 ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals Inc. Healthcare 4.28 3.79 2.9 12.26 25.05 0
#10 Denali Therapeutics Inc. Denali Therapeutics Inc. Healthcare 4.15 2.71 9.13 -5.14 -7.72 0
#11 Biogen Biogen Healthcare 4.07 1.31 2.26 13.43 9.25 0
#12 Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. Healthcare 4.07 8.56 6.87 55.57 39.97 0

Zahlen Sie das Abonnement

Weitere Funktionen und Daten zur Analyse von Unternehmen und Portfolio sind nach Abonnement verfügbar